{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:47:25Z","timestamp":1760014045284},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[1994,7,1]],"date-time":"1994-07-01T00:00:00Z","timestamp":773020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1994,7,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The aim of the present study was to discover to what extent 1.24(OH)2D3 ointment (tacalcitol; 4 \u03bcg\/g) can modulate epidermal proliferation and keratinization, and several aspects of inflamation. Ten patients with psoriasis vulgaris were included in a placebo-controlled, double-blind study, using 1,24(OH)2D3 ointment (4\u03bcg\/g). Before, and after 8 weeks of treatment, punch biopsies were taken from lesions treated with the active agent and placebo-treated lesions. An immunohistochemical study was carried out using monoclonal antibodies against the hyperproliferation-associated keratin 16, against cycling nuclei, filaggrin, involucrin, T lymphocytes, Langerhans cells, CD14 and polymorphonuclear leucocytes (PMN).<\/jats:p><jats:p>The Wilcoxon test for matched pairs was used for statistical analysis of results. The biopsies from the lesions treated with the active agent showed a statistically significant change towards normalization of all aspects of inflammation studied, and of epidermal proliferation and keratinization, but there did not appear to be any effect on Langerhans cells. The only parameter which showed a significant alteration in the placebo-treated lesions was the number of cycling nuclei in the epidermis (P\u22640.02). However, the biopsies from the plaques treated with the active agent showed a greater decrease of cycling cells (decrease: Mactive=70, Mplacebo=53) and a lower P-value (\u22640.01).<\/jats:p><jats:p>We therefore conclude that at the cell biological level 1.24(OH)2D3 ointment (4\u03bcg\/g) has a substantial effect on several cell types, with regard to inflammation, epidermal proliferation and keratinization, with the exception of Langerhans cells.<\/jats:p>","DOI":"10.1111\/j.1365-2133.1994.tb08458.x","type":"journal-article","created":{"date-parts":[[2006,7,30]],"date-time":"2006-07-30T19:36:12Z","timestamp":1154288172000},"page":"57-63","source":"Crossref","is-referenced-by-count":38,"title":["The effect of tacalcitol (1,24(OH)2D3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study"],"prefix":"10.1093","volume":"131","author":[{"given":"M.J.","family":"PGERRITSEN","sequence":"first","affiliation":[{"name":"Department of Dermatology. University Hospital Nijmegen, PO Box 9101. 6500 HB Nijmege, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.B.","family":"MBOEZEMAN","sequence":"additional","affiliation":[{"name":"Department of Dermatology. University Hospital Nijmegen, PO Box 9101. 6500 HB Nijmege, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.M.J.J.","family":"VAN VLIJMEN-WILLEMS","sequence":"additional","affiliation":[{"name":"Department of Dermatology. University Hospital Nijmegen, PO Box 9101. 6500 HB Nijmege, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.C.M.","family":"VAN DE KERKHOF","sequence":"additional","affiliation":[{"name":"Department of Dermatology. University Hospital Nijmegen, PO Box 9101. 6500 HB Nijmege, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1994,7,1]]},"reference":[{"key":"2023013105394281200_b1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2133.1986.tb06236.x","article-title":"An open study of vitamin D3 treatment in psoriasis vulgaris","volume":"115","author":"Morimoto","year":"1986","journal-title":"Br J Dermatol"},{"key":"2023013105394281200_b2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2133.1986.tb06237.x","article-title":"Successful treatment of psoriasis with topical application of active vitamin D3 analogue, 1\u03b1,24-dihydroxycholecalciferol","volume":"115","author":"Kato","year":"1986","journal-title":"Br J Dermatol"},{"key":"2023013105394281200_b3","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0190-9622(88)70207-8","article-title":"A novel approach for the evaluation and treatment of psoriasis","volume":"19","author":"Smith","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"2023013105394281200_b4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2133.1990.tb06287.x","article-title":"van de Kerkhof PCM. DNA content and Ks8.12 binding of the psoriatic lesion during treatment with the vitamin D3 analogue MC903 and betamethasone","volume":"123","author":"de Mare","year":"1990","journal-title":"Br J Dermatol"},{"key":"2023013105394281200_b5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0140-6736(91)92157-W","article-title":"Double-bind, right\/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris","volume":"337","author":"Kragballe","year":"1991","journal-title":"Lancet"},{"key":"2023013105394281200_b6","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1172\/JCI111557","article-title":"Inhibition of T lymphocyte mitogenesis by 1.25 dihydroxyvitamin D3 (calcitriol)","volume":"74","author":"Rigby","year":"1984","journal-title":"J Clin Invest"},{"key":"2023013105394281200_b7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0952-3278(88)90087-7","article-title":"In vivo effects of 1.25 dihydroxyvitamin D3 and minerals on synthesis of leukotriene B4 and 5-hydroxyeicostetraenoic acid by rat peritoneal neutrophils","volume":"32","author":"Tanaka","year":"1988","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2023013105394281200_b8","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2133.1987.tb04936.x","article-title":"Topically active vitamin D3 analogue, 1\u03b1,24-dihydroxycholecalciferol, has an antiproliferative effect on the epidermis of guinea pig skin","volume":"117","author":"Kato","year":"1987","journal-title":"Br J Dermatol"},{"key":"2023013105394281200_b9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2133.1991.tb00565.x","article-title":"Simultaneous assessment of inflammation and epidermal proliferation in psoriatic plaques during long-term treatment with the vitamin D3 analogue MC 903: modulations and interrelations","volume":"124","author":"de Jong","year":"1991","journal-title":"Br J Dermatol"},{"key":"2023013105394281200_b10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000248424","article-title":"Vitamin D3 in dermatology: a critical appraisal","volume":"178","author":"Czarnetzki","year":"1989","journal-title":"Dermatologica"},{"key":"2023013105394281200_b11","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1365-2133.1993.tb00263.x","article-title":"Topical treatment of psoriatic plaques with 1,25-dihydroxyvitamin D3: a cell biological study","volume":"128","author":"Gerritsen","year":"1993","journal-title":"Br J Dermatol"},{"key":"2023013105394281200_b12","first-page":"1407","article-title":"Effect of externally applied 1\u03b1,24(R)-(OH)2D3 on the kinetics of epidermal keratinocytes in the psoriatic focus","volume":"99","author":"Kawara","year":"1989","journal-title":"Jpn J Dermatol"},{"key":"2023013105394281200_b13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1346-8138.1990.tb03714.x","article-title":"Effect of 1,24 R-dihydroxyvitamin D3 on the growth of human keratinocytes","volume":"17","author":"Matsumoto","year":"1990","journal-title":"J Dermatol"},{"key":"2023013105394281200_b14","doi-asserted-by":"crossref","first-page":"970","DOI":"10.2336\/nishinihonhifu.51.970","article-title":"Investigation of clinical effects of TV-02 ointment in the treatment of psoriasis","volume":"51","author":"Nakamizo","year":"1989","journal-title":"The Nishi Nihon Journal of Dermatology"},{"key":"2023013105394281200_b15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2336\/nishinihonhifu.52.97","article-title":"Clinical studies on ointment of TV-02 (1\u03b1,24R-(OH)2D3 ointment against psoriasis and keratosis","volume":"52","author":"Nagae","year":"1990","journal-title":"The Nishi Nihon Journal of Dermatology"},{"key":"2023013105394281200_b16","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1365-4362.1983.tb02198.x","article-title":"Reproducibility of clinical trials of topical glucocorticosteroids","volume":"22","author":"Fredriksson","year":"1983","journal-title":"Int J Dermatol"},{"key":"2023013105394281200_b17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ijc.2910310104","article-title":"Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation","volume":"31","author":"Gerdes","year":"1983","journal-title":"Int J Cancer"},{"key":"2023013105394281200_b18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00372711","article-title":"MON-150, a versatile monoclonal antibody against involucrin: characterization and applications","volume":"284","author":"van Duijnhoven","year":"1992","journal-title":"Arch Dermatol Res"},{"key":"2023013105394281200_b19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1432-0436.1986.tb00395.x","article-title":"Monoclonal antibodies to various acidic (type I) cytokeratins of stratified epithelia","volume":"31","author":"Huszar","year":"1986","journal-title":"Differentiation"},{"key":"2023013105394281200_b20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0014-4827(87)90166-2","article-title":"Differentiation-related changes of cytokeratin expression in cultured keratinocytes and in fetal, newborn, and adult epidermis","volume":"171","author":"van Muijen","year":"1987","journal-title":"Exp Cell Res"},{"key":"2023013105394281200_b21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(89)90427-3","article-title":"4","volume":"ii","author":"Bogman","year":"1989","journal-title":"Lancet"},{"key":"2023013105394281200_b22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2133.1994.tb02897.x","article-title":"Response of the clinically uninvolved skin of psoriatic patients to repeated tape stripping during cyclosporin A treatment","volume":"130","author":"Gerritsen","year":"1994","journal-title":"Br J Dermatol"},{"key":"2023013105394281200_b23","first-page":"611A","article-title":"Enumeration of T-cell subpopulations in lupus erythematosus lesions using monoclonal antibodies","volume":"30","author":"Synkowski","year":"1982","journal-title":"Clin Res"},{"key":"2023013105394281200_b24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1346-8138.1991.tb03057.x","article-title":"Abnormal distribution of epidermal protein antigens in psoriatic epidermis","volume":"18","author":"Watanabe","year":"1991","journal-title":"J Dermatol"},{"key":"2023013105394281200_b25","first-page":"187","volume-title":"Psoriasis. Proceedings of the 1st International Symposium","author":"Muller","year":"1971"},{"key":"2023013105394281200_b26","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2340\/0001555565390397","article-title":"Psoriasis infiltrating cell immunophenotype: changes induced by PUVA or corticosteroid treatment in T-cell subsets, Langerhans cell and interdigitating cells","volume":"65","author":"Bos","year":"1985","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"2023013105394281200_b27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/1523-1747.ep12506332","article-title":"Expression of HLA-DR antigen in skin from patients with psoriasis","volume":"78","author":"Morhenn","year":"1982","journal-title":"J Invest Dermatol"},{"issue":"Suppl. 24","key":"2023013105394281200_b28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2133.1983.tb11567.x","article-title":"Langerhans cells and T-cell subsets in psoriasis","volume":"109","author":"Swain","year":"1983","journal-title":"Br J Dermatol"},{"key":"2023013105394281200_b29","first-page":"343","volume-title":"Psoriasis","author":"Haftek","year":"1991","edition":"2nd edn."},{"key":"2023013105394281200_b30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/1523-1747.ep12276343","article-title":"Effect of 1,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions","volume":"86","author":"Smith","year":"1986","journal-title":"J Invest Dermatol"},{"key":"2023013105394281200_b31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2165\/00003495-199243030-00007","article-title":"Calcipotriol. A review of its pharmacological properties and therapeutic use in psoriasis vulgaris","volume":"43","author":"Murdoch","year":"1992","journal-title":"Drugs"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.1994.tb08458.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/131\/1\/57\/48958523\/bjd0057.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/131\/1\/57\/48958523\/bjd0057.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T19:37:39Z","timestamp":1707161859000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/131\/1\/57\/6681031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,7,1]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[1994,7,1]]},"published-print":{"date-parts":[[1994,7,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.1994.tb08458.x","relation":{},"ISSN":["1365-2133","0007-0963"],"issn-type":[{"value":"1365-2133","type":"electronic"},{"value":"0007-0963","type":"print"}],"subject":[],"published-other":{"date-parts":[[1994,7,1]]},"published":{"date-parts":[[1994,7,1]]}}}